JF
MDGL icon

Jump Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jump Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$626K Sell
1,195
-18,026
-94% -$8.61M 0.01% 1135
2025
Q4 		$11.2M Sell
19,221
-1,735
-8% -$886K 0.14% 179
2025
Q3 		$9.61M Buy
+20,956
New +$7.82M 0.12% 226
2025
Q1 		– Sell
-682
Closed -$210K – 1848
2024
Q4 		$210K Buy
+682
New +$192K ﹤0.01% 1466
2023
Q4 		– Sell
-2,359
Closed -$345K – 2048
2023
Q3 		$345K Buy
2,359
+868
+58% +$163K 0.01% 1228
2023
Q2 		$344K Sell
1,491
-19,304
-93% -$5.23M 0.01% 1239
2023
Q1 		$5.04M Buy
20,795
+16,207
+353% +$4.42M 0.21% 149
2022
Q4 		$1.33M Buy
+4,588
New +$449K 0.07% 378

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jump Financial's MDGL Position: Q1 2026 in Review

Jump Financial reduced its Madrigal Pharmaceuticals (MDGL) stake by 94% in Q1 2026, selling an estimated $8.61M and leaving 1,195 shares worth $626K. The position accounts for 0.01% of the portfolio, ranked #1135.

Jump Financial first reported a position in MDGL in Q4 2022 and has held it in 8 quarters since. The position peaked at $11.2M in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Jump Financial held 1,195 shares of Madrigal Pharmaceuticals worth $626K as of Q1 2026.
  • Jump Financial sold 18,026 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $8.61M.
  • Madrigal Pharmaceuticals made up 0.01% of Jump Financial's portfolio in Q1 2026, its #1135 holding.
  • Jump Financial first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
  • Jump Financial's Madrigal Pharmaceuticals position peaked at $11.2M in Q4 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.